Australian Super Pty LTD Amneal Pharmaceuticals, Inc. Transaction History
Australian Super Pty LTD
- $20.5 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
258Shares Held
150MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA18MShares$209 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...